31 / 33
Data cut-off: 12 June 2017
*Occurring in ≥15% patients
#
Grade unknown for one patient in SoC arm
ALT, alanine aminotransferase; AST, aspartate aminotransferase; SoC, standard-of-care
0
10
20
30
40
50
60
70
Incidence (%)
FLAURA: Similar if not better toxicity profile with osimertinib
Osimertinib
SoC
Ramalingam, ESMO 2017